Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baozhu Keli is a newly developed traditional Chinese medicine (TCM) herbal combination designed for the treatment of ovarian aging and related conditions such as perimenopause. It is currently being evaluated in clinical trials to determine its safety and efficacy in improving ovarian function and alleviating symptoms associated with ovarian aging. The formulation consists of multiple Chinese herbs, but the specific ingredients and their mechanisms have not been disclosed in available sources. The drug is intended to provide an alternative or adjunctive therapy for women experiencing diminished ovarian reserve or early menopause, leveraging principles of TCM[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baozhu Keli.